Are Post-Care Recommendations Following Upper-Face Botulinum Toxin Treatment Scientifically Necessary? A Retrospective Study Based on 5000 Patients
Toxins · 2025
DOI: 10.3390/toxins17080372 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Toxins, 2025. Verfasst von Adriano Santorelli und 7 weiteren Autor:innen. Beteiligte Einrichtung: "Santorelli and Partners", Via Raffaele Morghen, 88, 80129 Napoli, NA, Italy. Hauptthemen laut MEDLINE: Botulinum Toxins, Skin Aging, Aftercare, Botulinum Toxins, Type A. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: A.I.T.E.B.
Abstract (Originalsprache)
Background
Patient care following botulinum toxin injections has long been guided by anecdotal instructions, often based on theoretical considerations. This study evaluates the necessity of extended post-treatment instructions by analyzing outcomes and satisfaction in patients who followed only a 10 min precaution protocol. Materials and Methods: A retrospective, multicentric study was conducted across six Italian centers, analyzing 5014 patients treated with botulinum toxin for upper facial wrinkles between 2015 and 2020. Outcomes included adverse effects—particularly upper eyelid ptosis—and patient satisfaction. Follow-up was performed at two weeks.
Results
No cases of upper eyelid ptosis were observed. Among 4000 patients who attended follow-up, adverse effects occurred in only 5.99%, notably lower than rates reported in the literature. Of the 2010 patients who completed the satisfaction questionnaire, 90% reported being very satisfied. These findings support the safety of limiting post-treatment instructions to 10 min.
Conclusions
Our findings indicate that omitting extended post-injection instructions does not negatively impact patient satisfaction or complication rates. Given the toxin’s rapid internalization and localized effect, extended behavioral restrictions may be redundant. However, the absence of a control group and lack of statistical analyses limit the strength of these conclusions. In addition, this is a short-term study. Future prospective, randomized trials are needed to develop evidence-based post-care protocols to optimize esthetic outcomes, patient safety, and long-term efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- "Santorelli and Partners", Via Raffaele Morghen, 88, 80129 Napoli, NA, Italy.
- Independent Researcher, Via Claudio Monteverdi, 2, 50144 Firenze, FI, Italy.
- Agorà, Via dei Ciclamini, 23, 20147 Milano, MI, Italy.
- Independent Researcher, Viale Schiocchi, 40, 41124 Modena, MO, Italy.
- Independent Researcher, Via Galata, 37/4, 16121 Genova, GE, Italy.
- Residency Program in Plastic, Reconstructive and Aesthetic Surgery, Campus Biomedico University, Via Álvaro del Portillo, 21, 00128 Roma, RM, Italy.
ORCID-Profile: Adriano Santorelli, Salvatore Piero Fundarò, Martina Ponzo, Stefano Avvedimento, Stefano Uderzo
Förderung
- A.I.T.E.B
Zitieren
APA
Santorelli, A., Salti, G., Cavallini, M., Fundarò, S. P., Basso, M., Ponzo, M., Avvedimento, S., & Uderzo, S. (2025). Are Post-Care Recommendations Following Upper-Face Botulinum Toxin Treatment Scientifically Necessary? A Retrospective Study Based on 5000 Patients. Toxins. https://doi.org/10.3390/toxins17080372
Vancouver
Santorelli A, Salti G, Cavallini M, Fundarò SP, Basso M, Ponzo M, et al. Are Post-Care Recommendations Following Upper-Face Botulinum Toxin Treatment Scientifically Necessary? A Retrospective Study Based on 5000 Patients. Toxins. 2025. doi:10.3390/toxins17080372
BibTeX
@article{Santorelli2025,
author = {Santorelli, Adriano and Salti, Giovanni and Cavallini, Maurizio and Fundarò, Salvatore Piero and Basso, Matteo and Ponzo, Martina and Avvedimento, Stefano and Uderzo, Stefano},
title = {Are Post-Care Recommendations Following Upper-Face Botulinum Toxin Treatment Scientifically Necessary? A Retrospective Study Based on 5000 Patients},
journal = {Toxins},
year = {2025},
doi = {10.3390/toxins17080372}
}
EUVIMED